Search for Clinical Trial Results

Sponsored By

Heparin-induced Thrombocytopenia - 24 Studies Found

Status Study
Terminated Study Name: Rivaroxaban for Treatment of Patients With Suspected or Confirmed Heparin-Induced Thrombocytopenia
Condition: Heparin-induced Thrombocytopenia
Date: 2012-05-11
Interventions: Drug: Rivaroxaban Rivaroxaban 15 mg bid until HIT excluded by local laboratory assay or platelets recove
Completed Study Name: Multi-Center Single Arm Trial to Determine The Effectiveness of Warfarin Therapy Duration For Heparin-Induced Thrombocytopenia (HIT)
Condition: Heparin-induced Thrombocytopenia
Date: 2017-05-01
Interventions: Drug: Warfarin, NOAC duration of treatment
Completed Study Name: Heparin Induced Thrombocytopenia: Pharmacoeconomics
Condition: Heparin Induced Thrombocytopenia (HIT)
Date: 2007-04-02
Completed Study Name: Rapid Diagnosis of Heparin-Induced Thrombocytopenia in Surgical Critically Ill Patients
Condition: Heparin-induced Thrombocytopenia (HIT)
Date: 2013-08-01
Interventions:
  • Other: HEP score

Not yet recruiting Study Name: Optimizing the Diagnosis of Heparin Induced Thrombocytopenia
Condition: Heparin-induced Thrombocytopenia (HIT)
Date: 2017-04-10
Interventions: Diagnostic Test: Diagnostic algorithm The treating physician will complete an enrollment assessment incl
Completed Study Name: Heparin-induced Thrombocytopenia (HIT II) in Liver Transplant Recipients
Condition:
  • Heparin-induced Thrombocytopenia
  • Liver Transplantation
    • Date: 2012-03-30
Terminated Study Name: A Comparative Sudy Comparing Argatroban® IV vs Desirudin SC for Suspected HIT With or Without Thrombosis Syndrome
Condition: Suspected Heparin-Induced Thrombocytopenia
Date: 2008-11-06
Interventions: Drug: Desirudin or Argatroban® Desirudin 15mg SC Argatroban® IV dosing per Package Insert
Completed Study Name: Anticoagulant Therapy With Bivalirudin in the Performance of Percutaneous Coronary Intervention in Patients With Heparin-Induced Thrombocytopenia (AT BAT, First Inning)
Condition:
  • Heparin-Induced Thrombocytopenia
  • Thrombosis

Date: 2002-08-14
Interventions: Drug: bivalirudin Bivalirudin therapy will be given as a 0.75-mg/kg intravenous bolus and 1.75-mg/kg/h i
Completed Study Name: Immunogenetics of Heparin-Induced Thrombocytopenia: Aim 2
Condition: Heparin-induced Thrombocytopenia
Date: 2015-06-03
Interventions: Procedure: Blood Draw A one time blood draw of 150 milliliters will be performed using a vein in the par
Completed Study Name: Retrospective Registry of Patients With Acute Heparin-induced Thrombocytopenia Type II
Condition: Acute HIT II (Heparin-induced Thrombocytopenia Type II)
Date: 2011-01-27
Interventions:
  • Drug: lepirudin lepirudin
<<< Previous | Next >>>